Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tarsus Pharmaceuticals (TARS)
NASDAQ:TARS
RESEARCH TOOLSreports
Holding TARS?
Track your performance easily
| Sep 24 | Jun 24 | Dec 23 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 48.12M | $ 40.81M | $ 13.08M | $ 1.87M | - |
| Gross Profit | $ 44.88M | $ 37.81M | $ 11.86M | $ 1.49M | - |
| EBIT | $ -20.98M | $ -31.18M | $ -40.94M | $ -38.32M | $ -30.61M |
| EBITDA | $ -20.55M | $ -30.59M | $ -40.60M | $ -38.08M | $ -28.83M |
| Net Income Common Stockholders | $ -23.42M | $ -31.18M | $ -41.90M | $ -39.15M | $ -30.61M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 316.95M | $ 323.58M | $ 227.44M | $ 246.88M | $ 178.23M |
| Total Assets | $ 376.30M | $ 376.84M | $ 265.49M | $ 268.33M | $ 188.93M |
| Total Debt | $ 71.71M | $ 71.58M | $ 29.82M | $ 29.71M | $ 24.61M |
| Net Debt | $ -245.24M | $ -252.00M | $ -197.62M | $ -217.18M | $ -153.62M |
| Total Liabilities | $ 138.82M | $ 124.60M | $ 68.50M | $ 54.67M | $ 41.20M |
| Stockholders Equity | $ 237.48M | $ 252.25M | $ 196.99M | $ 213.66M | $ 147.73M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -8.93M | $ -15.44M | $ -39.34M | $ -36.74M | $ -24.61M |
| Operating Cash Flow | $ -8.65M | $ -14.40M | $ -39.34M | $ -32.36M | $ -23.83M |
| Investing Cash Flow | $ 3.13M | $ -40.52M | $ 17.85M | $ 47.37M | $ 64.09M |
| Financing Cash Flow | $ 639.00K | $ 42.32M | $ 19.76M | $ 104.89M | $ 510.00K |